tm logo
Trademark Search
MYCIT

View On IC.GC.CA

MYCIT
REGISTERED

on 03 Aug 2022

Last Applicant/ Owned by

BIONTECH SE

An der Goldgrube 1255131 Mainz

DE

Serial Number

1985685 filed on 01st Jul 2019

Registration Number

TMA1136180 registered on 03rd Aug 2022

Registration expiry Date

01st Jul 2029

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

MYCIT

Trademark usage description

pharmaceutical products for the treatment of cancer, in particular based on nucleic acids and proteins; personalised patient-specific medicinal produc Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of cancer, in particular based on nucleic acids and proteins; personalised patient-specific medicinal products, in particular based on nucleic acids and proteins for use in oncology.

Classification kind code

11

Class [009]
Scientific apparatuses and instruments for the detection and collection of mutations in cancer patients; software algorithms as software programs for the detection and collection of mutations in cancer patients.

Classification kind code

11

Class [010]
High-throughput analytical instruments, in particular instruments for next-generation sequencing [NGS] for medical issues, as well as for gene expression profiling and for the detection of epigenetic changes.

Classification kind code

11

Class [042]
Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biological, genetic, biotechnological and bioinformatic methods, in particular by means of next-generation sequencing; diagnostics of tumour markers for personalised treatment as scientific laboratory services or as part of scientific research for medical purposes.

Classification kind code

11

Class [044]
Medical, veterinary-medical and pharmaceutical advisory services, in particular in the selection of suitable treatments for cancer diseases of all kinds; performance of analyses and treatments as part of personalized cancer immunotherapy; Provision of cancer treatments based on nucleic acids and checkpoint inhibitors.

Classification kind code

11

Mark Details

Serial Number

1985685

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 03rd Aug 2021		Agent Changed
Submitted for opposition 20
on 12th Jan 2021		Examiner's First Report
Submitted for opposition 223
on 12th Jan 2021		Total Provisional Refusal
Submitted for opposition 22
on 02th Dec 2020		Search Recorded
Submitted for opposition 256
on 20th Jul 2020		Notification of Possible Opposition Sent
Submitted for opposition 257
on 19th Sep 2019		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 18th Sep 2019		Created
Submitted for opposition 31
on 18th Sep 2019		Formalized
Submitted for opposition 228
on 01st Jul 2019		International Registration
Submitted for opposition 30
on 01st Jul 2019		Filed